Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China

Jianghan Chen, Ashok Varma, Mara R Diaz, Anastasia P Litvintseva, Kurt K Wollenberg, Kyung J Kwon-Chung, Jianghan Chen, Ashok Varma, Mara R Diaz, Anastasia P Litvintseva, Kurt K Wollenberg, Kyung J Kwon-Chung

Abstract

To determine the population structure of the cryptococcosis agents in China, we analyzed the genotype of 120 Cryptococcus neoformans and 9 Cryptococcus gattii strains isolated from 1980 through 2006 from cryptococcosis patients residing in 16 provinces of mainland China. A total of 71% (91/129) of the clinical strains isolated from 1985 through 2006 were from patients without any apparent risk factors. Only 8.5% (11/129) were from AIDS patients; the remaining 20.5% (27/129) were from patients with underlying diseases other than HIV infection. One hundred twenty of the 129 isolates were C. neoformans serotype A, mating type MATalpha strains that exhibited an identical M13-based VNI subtype, which was distinguishable from the reference VNI molecular type. The 9 remaining isolates were serotype B, MATalpha strains of C. gattii and portrayed a typical VGI molecular type. Data analyzed from multilocus sequences showed no variation and that these Chinese C. neoformans isolates belong to a cluster that has phylogenetically diverged from the VNI reference strain. Our finding that most cryptococcosis patients in China had no apparent risk factor is in stark contrast with reports from other countries.

Figures

Figure 1
Figure 1
Mainland China. The numbers in the boxes represent strains used in this study that were isolated during 1980–2006 from each region.
Figure 2
Figure 2
DNA fingerprint patterns of 12 Cryptococcus neoformans strains from China and the molecular type reference strains. A) M13-based PCR pattern. B) URA5 restriction fragment length polymorphism. Lanes: 1, VNI; 2–12, 11 Chinese strains; 13, H99; 14, Chinese strain B-4587; 15, VNBt63; 16, VNI; 17, VNIII; 18, VNII; 19, VNI; 20, marker.
Figure 3
Figure 3
The phylogenetic tree for maximum parsimony analysis composed on the basis of the M13-PCR pattern of 12 Chinese Cryptococcus neoformans strains. Numbers above the branches represent bootstrap support percentages based on 500 replicates. The scale bar represents the inferred number of steps along a branch of the tree.
Figure 4
Figure 4
Genetic relationship of multilocus sequence typing (MLST) genotypes among 94 isolates of Cryptococcus neoformans serotype A (88 strains from Litvintseva et al. [10]) and 6 representative Chinese strains) visualized by the neighbor-joining dendrogram. Numbers on each branch indicate the bootstrap values >50%, based on 500 replicates. Vertical lines represent strains with identical genotypes. Arrows indicate MLST results for Chinese strains.
Figure 5
Figure 5
Virulence in mice. Mice were intranasally infected with 5 × 107 yeast cells from the 3 Chinese Cryptococcus neoformans strains, CHC114, CHC193, and CHC 186, and compared with H99 and the reference strains VNI and VNII for survival.
Figure 6
Figure 6
Comparison of the PCR patterns of 9 Chinese Cryptococcus gattii isolates with reference C. gattii strains. A) M13, B) (GACA)4, C) URA5. Lanes: 1–9, Chinese strains; 10, VGIV; 11, VGIII; 12, VGII; 13, VGI; 14, marker.

References

    1. Kwon-Chung KJ, Varma A. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res. 2006;6:574–84. 10.1111/j.1567-1364.2006.00088.x
    1. Kwon-Chung KJ, Bennett JE. Medical mycology. Philadelphia: Lea & Febiger; 1992.
    1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS—100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995;8:515–48.
    1. Litvintseva AP, Thakur R, Reller LB, Mitchell TG. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in sub-Saharan Africa. Eukaryot Cell. 2005;192:888–92.
    1. Meyer W, Marszewska K, Amirmostofian M, Igreja RP, Hardtke C, Methling K, et al. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA—a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis. 1999;20:1790–9. 10.1002/(SICI)1522-2683(19990101)20:8<1790::AID-ELPS1790>;2-2
    1. Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E. IberoAmerican Cryptococcal Study Group. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis. 2003;9:189–95.
    1. Cogliati M, Allaria M, Tortorano AM, Viviani MA. Genotyping Cryptococcus neoformans with specific primers designed from PCR-fingerprinting bands sequenced using a modified PCR-based strategy. Med Mycol. 2000;38:97–103. 10.1080/714030933
    1. Boekhout T, Theelen B, Diaz M, Fell JW, Hop WC, Abeln EC, et al. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology. 2001;147:891–907.
    1. Diaz MR, Boekhaut T, Kiesling T, Fell J. Comparative analysis of the intergenic spacer regions and population structure of the species complex of the pathogenic yeast Cryptococcus neoformans. FEMS Yeast Res. 2005;5:1129–40. 10.1016/j.femsyr.2005.05.005
    1. Litvintseva AP, Thakur R, Vilgalys R, Mitchell TG. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics. 2005;172:2223–38. 10.1534/genetics.105.046672
    1. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A. 2004;101:17258–63. 10.1073/pnas.0402981101
    1. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984;120:123–30.
    1. Huang LB, Zhang ZJ, Xu GY, Murong SX. Clinical analysis of 32 cryptococcal meningitis patients [in Chinese]. J Clin Neurol. 2002;15:371–2.
    1. Wu CH, Wang HY, Yang BS, Lu X, Wang JM, Lin JS. Analysis of the outcome of 46 patients with cryptococcal meningitis [in Chinese]. Zhonghua Shen Jing Ge Za Zhi. 2002;35:102.
    1. Zu LP, Peng XZ, Shi YZ, Weng XH. One case of AIDS associated disseminated cryptococcosis [in Chinese]. Chin J Infect Dis. 2004;22:301.
    1. Gua AH, Hu XQ. Clinical features of 101 cryptococcal meningitis [in Chinese]. Chin J Infect Dis. 2005;38:445–7.
    1. Gu JL, Wen H, Chen JH, Chen YC, Li JC. Clinical analysis of 39 cryptococcal meningitis [in Chinese]. J Clin Dermatol. 2005;34:801–3.
    1. Chen JH, Wen H, Chen SX, Wu JH, Zhu YJ, Xu H. The adverse events of amphotericin B and its management during the treatment of cryptococcal meningitis [in Chinese]. Acad J Second Military Med Univ. 2005;26:456–7.
    1. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol. 1982;15:535–7.
    1. Perfect JR, Lang SD, Durack DT. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol. 1980;101:177–94.
    1. Kwon-Chung KJ, Bennett JE, Rhodes JC. Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Van Leeuwenhoek. 1982;48:25–38. 10.1007/BF00399484
    1. Lengeler KB, Cox GM, Heitman J. Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus. Infect Immun. 2001;69:115–22. 10.1128/IAI.69.1.115-122.2001
    1. Varma A, Wu S, Guo N, Liao W, Lu G, Li A, et al. Identification of a novel gene URE2 that functionally complements a urease negative clinical strain of Cryptococcus neoformans. Microbiology. 2006;152:3723–31. 10.1099/mic.0.2006/000133-0
    1. Swofford DL. PAUP*: Phylogenetic analysis using parsimony (*and other methods). Version 4. Sunderland (MA): Sinauer Associates, Inc.; 2002.
    1. Bell M, Archibald LK, Nwanyanwu O, Dobbie H, Tokars J, Kazembe P, et al. Seasonal variation in the etiology of bloodstream infections in a febrile inpatient population in a developing country. Int J Infect Dis. 2001;5:63–9. 10.1016/S1201-9712(01)90027-X
    1. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status of Crytococcus neoformans serotype A isolates. J Clin Microbiol. 1999;37:838–40.
    1. Barreto de Oliveira MT, Boekhaut T, Theelen B, Hagen F, Baroni FA, Lazera MS, et al. Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil. [PMID: 15004118]. J Clin Microbiol. 2004;42:1356–9. 10.1128/JCM.42.3.1356-1359.2004
    1. Jain N, Wickes BL, Keller SM, Fu J, Casadevall A, Jain P, et al. Molecular epidemiology of clinical Cryptococcus neoformans. J Clin Microbiol. 2005;43:5733–42. 10.1128/JCM.43.11.5733-5742.2005
    1. Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: a 9 year survey (1985–1993). French Cryptococcosis Study Group. Clin Infect Dis. 1996;23:82–90.
    1. Hajjeh RA, Conn LA, Stephen DS, Baughman W, Hamill R, Graviss E, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis. 1999;179:449–54. 10.1086/314606
    1. Moosa MYS, Coovadia YM. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. Clin Infect Dis. 1997;24:131–4.
    1. Chen S, Sorrell T, Nimmo G, Speed B, Currrie B, Ellis D, et al. Epidemiology and host-and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis. 2000;31:499–508. 10.1086/313992
    1. Meletiadis J, Walsh TJ, Choi EH, Pappas PG, Ennis D, Douglas J, et al. Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients. Med Mycol. 2007;45:513–8. 10.1080/13693780701390140
    1. Casadevall A, Perfect JR. Cryptococcus neoformans. Washington: ASM Press; 1998.
    1. Friedman GD. The rarity of cryptococcosis in northern California: the 10-year experience of a large defined population. Am J Epidemiol. 1983;117:230–4.
    1. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al. Population-based multistate active surveillance and risk factors in human immunodeficiency virus-Infected persons. J Infect Dis. 1999;179:449–54. 10.1086/314606
    1. Kwon-Chung KJ, Hill WB. Sexuality and pathogenicity of Filobasidiella neoformans (Cryptococcus neoformans). In: Vanbreuseghem R, DeVroey C, editors. Sexuality and pathogenicity of fungi. New York: Masson; 1981. p. 243–50.
    1. Lo D. Cryptococcosis in the Northern Territory. Med J Aust. 1976;2:825,828.
    1. Sorvillo F, Beall G, Turner PA, Beer VL, Kovacs AA, Kerndt PR. Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County. AIDS. 1997;11:673–9. 10.1097/00002030-199705000-00016

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever